Recommendations for Institutions Transitioning to High-Sensitivity Troponin Testing: JACC Scientific Expert Panel

James L. Januzzi, Simon A. Mahler, Robert H. Christenson, Jennifer Rymer, L. Kristin Newby, Richard Body, David A. Morrow, Allan S Jaffe

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

High-sensitivity cardiac troponin (hs-cTn) I or T methods have been in use in certain regions for years but are now increasingly globally adopted, including in the United States. Accordingly, inevitable challenges are created for institutions transitioning from conventional cardiac troponin (cTn) assays. hs-cTn assays have higher analytic precision at lower concentrations, yielding greater clinical sensitivity for myocardial injury and allowing accurate recognition of small changes in troponin concentration (rise or fall) within a short time frame. Although much of the knowledge regarding troponin biology that was applicable with older troponin assays still holds true, considerable education regarding the differences between conventional cTn and hs-cTn is needed before medical systems convert to the newer methods. This includes a basic understanding of how hs-cTn testing differs from conventional cTn testing and how it is best deployed in different settings, such as the emergency department and inpatient services. This Expert Panel will review important concepts for institutional transition to hs-cTn methodology, providing recommendations useful for education before implementation.

Original languageEnglish (US)
Pages (from-to)1059-1077
Number of pages19
JournalJournal of the American College of Cardiology
Volume73
Issue number9
DOIs
StatePublished - Mar 12 2019

Fingerprint

Troponin
Education
Troponin T
Troponin I
Hospital Emergency Service
Inpatients

Keywords

  • laboratory testing
  • myocardial infarction
  • troponin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Recommendations for Institutions Transitioning to High-Sensitivity Troponin Testing : JACC Scientific Expert Panel. / Januzzi, James L.; Mahler, Simon A.; Christenson, Robert H.; Rymer, Jennifer; Newby, L. Kristin; Body, Richard; Morrow, David A.; Jaffe, Allan S.

In: Journal of the American College of Cardiology, Vol. 73, No. 9, 12.03.2019, p. 1059-1077.

Research output: Contribution to journalReview article

Januzzi, James L. ; Mahler, Simon A. ; Christenson, Robert H. ; Rymer, Jennifer ; Newby, L. Kristin ; Body, Richard ; Morrow, David A. ; Jaffe, Allan S. / Recommendations for Institutions Transitioning to High-Sensitivity Troponin Testing : JACC Scientific Expert Panel. In: Journal of the American College of Cardiology. 2019 ; Vol. 73, No. 9. pp. 1059-1077.
@article{03306833ddd44080a4d3447bf92f951a,
title = "Recommendations for Institutions Transitioning to High-Sensitivity Troponin Testing: JACC Scientific Expert Panel",
abstract = "High-sensitivity cardiac troponin (hs-cTn) I or T methods have been in use in certain regions for years but are now increasingly globally adopted, including in the United States. Accordingly, inevitable challenges are created for institutions transitioning from conventional cardiac troponin (cTn) assays. hs-cTn assays have higher analytic precision at lower concentrations, yielding greater clinical sensitivity for myocardial injury and allowing accurate recognition of small changes in troponin concentration (rise or fall) within a short time frame. Although much of the knowledge regarding troponin biology that was applicable with older troponin assays still holds true, considerable education regarding the differences between conventional cTn and hs-cTn is needed before medical systems convert to the newer methods. This includes a basic understanding of how hs-cTn testing differs from conventional cTn testing and how it is best deployed in different settings, such as the emergency department and inpatient services. This Expert Panel will review important concepts for institutional transition to hs-cTn methodology, providing recommendations useful for education before implementation.",
keywords = "laboratory testing, myocardial infarction, troponin",
author = "Januzzi, {James L.} and Mahler, {Simon A.} and Christenson, {Robert H.} and Jennifer Rymer and Newby, {L. Kristin} and Richard Body and Morrow, {David A.} and Jaffe, {Allan S}",
year = "2019",
month = "3",
day = "12",
doi = "10.1016/j.jacc.2018.12.046",
language = "English (US)",
volume = "73",
pages = "1059--1077",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "9",

}

TY - JOUR

T1 - Recommendations for Institutions Transitioning to High-Sensitivity Troponin Testing

T2 - JACC Scientific Expert Panel

AU - Januzzi, James L.

AU - Mahler, Simon A.

AU - Christenson, Robert H.

AU - Rymer, Jennifer

AU - Newby, L. Kristin

AU - Body, Richard

AU - Morrow, David A.

AU - Jaffe, Allan S

PY - 2019/3/12

Y1 - 2019/3/12

N2 - High-sensitivity cardiac troponin (hs-cTn) I or T methods have been in use in certain regions for years but are now increasingly globally adopted, including in the United States. Accordingly, inevitable challenges are created for institutions transitioning from conventional cardiac troponin (cTn) assays. hs-cTn assays have higher analytic precision at lower concentrations, yielding greater clinical sensitivity for myocardial injury and allowing accurate recognition of small changes in troponin concentration (rise or fall) within a short time frame. Although much of the knowledge regarding troponin biology that was applicable with older troponin assays still holds true, considerable education regarding the differences between conventional cTn and hs-cTn is needed before medical systems convert to the newer methods. This includes a basic understanding of how hs-cTn testing differs from conventional cTn testing and how it is best deployed in different settings, such as the emergency department and inpatient services. This Expert Panel will review important concepts for institutional transition to hs-cTn methodology, providing recommendations useful for education before implementation.

AB - High-sensitivity cardiac troponin (hs-cTn) I or T methods have been in use in certain regions for years but are now increasingly globally adopted, including in the United States. Accordingly, inevitable challenges are created for institutions transitioning from conventional cardiac troponin (cTn) assays. hs-cTn assays have higher analytic precision at lower concentrations, yielding greater clinical sensitivity for myocardial injury and allowing accurate recognition of small changes in troponin concentration (rise or fall) within a short time frame. Although much of the knowledge regarding troponin biology that was applicable with older troponin assays still holds true, considerable education regarding the differences between conventional cTn and hs-cTn is needed before medical systems convert to the newer methods. This includes a basic understanding of how hs-cTn testing differs from conventional cTn testing and how it is best deployed in different settings, such as the emergency department and inpatient services. This Expert Panel will review important concepts for institutional transition to hs-cTn methodology, providing recommendations useful for education before implementation.

KW - laboratory testing

KW - myocardial infarction

KW - troponin

UR - http://www.scopus.com/inward/record.url?scp=85062028648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062028648&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2018.12.046

DO - 10.1016/j.jacc.2018.12.046

M3 - Review article

C2 - 30798981

AN - SCOPUS:85062028648

VL - 73

SP - 1059

EP - 1077

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 9

ER -